M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma
Translational Oncology · 2025-04 · 54 · 102324
DOI: 10.1016/j.tranon.2025.102324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2025-04. Verfasst von Tetsuya Fukui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujiwara Memorial Foundation.
Abstract (Originalsprache)
INTRODUCTION: Malignant pleural mesothelioma (MPM) is an aggressive malignancy with an unfavorable prognosis. Asbestos-activated macrophages may contribute to both oncogenesis and progression of MPM. This study aimed to clarify the biological and clinical significance of M2-like tumor-associated macrophages (TAMs) in MPM. METHODS: This retrospective study included 101 MPM patients who were diagnosed and started treatment between 1998 and 2010. The distribution of M2-like TAMs in the intratumoral and peritumoral regions was evaluated by immunohistochemistry using CD163 staining. Tumor proliferation was evaluated by Ki-67 staining. RESULTS: Intratumoral M2-like TAM density was significantly correlated with the pretreatment C-reactive protein level (r = 0.283, P = 0.004) and Ki-67 proliferation index (r = 0.498, P < 0.001). Peritumoral M2-like TAM density was also significantly correlated with the pretreatment C-reactive protein level (r = 0.255, P = 0.010) and Ki-67 proliferation index (r = 0.435, P < 0.001). Additionally, intratumoral M2-like TAM density was associated with histological subtype (P < 0.001), with higher densities observed in sarcomatoid tumors compared to epithelioid tumors. The overall survival rate was significantly worse in the intratumoral and peritumoral M2-like TAM-high groups (P = 0.044 and P = 0.046, respectively), particularly in patients with advanced-stage MPM. Multivariable analysis identified peritumoral M2-like TAM status (hazard ratio = 1.700, 95 % confidence interval: 1.034-2.796, P = 0.037), clinical stage, and histology as significant prognostic factors for overall survival. CONCLUSIONS: During MPM progression, M2-like TAMs may induce tumor cell proliferation and aggressiveness, contributing to the poor prognosis in MPM patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
- Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: rt_sumitomo@kuhp.kyoto-u.ac.jp.
- Department of Thoracic Surgery, Kurashiki Central Hospital, Okayama 710-0052, Japan.
- Department of Thoracic Surgery, Hyogo Prefectural Amagasaki General Medical Center, Hyogo 660-8550, Japan.
Förderung
- Fujiwara Memorial Foundation
Zitieren
APA
Fukui, T., Sumitomo, R., Menju, T., Kobayashi, M., Sakai, H., & Date, H. (2025). M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma. Translational Oncology, 54, 102324. https://doi.org/10.1016/j.tranon.2025.102324
Vancouver
Fukui T, Sumitomo R, Menju T, Kobayashi M, Sakai H, Date H. M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma. Translational Oncology. 2025;54:102324. doi:10.1016/j.tranon.2025.102324
BibTeX
@article{Fukui2025,
author = {Fukui, Tetsuya and Sumitomo, Ryota and Menju, Toshi and Kobayashi, Masashi and Sakai, Hiroaki and Date, Hiroshi},
title = {M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma},
journal = {Translational Oncology},
year = {2025},
volume = {54},
pages = {102324},
doi = {10.1016/j.tranon.2025.102324}
}
EUVIMED